ClinicaliQ Trial Snapshot
- Long-term Follow-up (LTFU) Study of Participants in Any iECURE Protocol Using an Investigational Product (IP) — Recruiting • Gastroenterology • NCT06805695.
- What is being tested: Long-term safety profile and durability of therapeutic response in participants who received investigational products (IP) across iECURE parent protocols, alongside natural history data collection in enrolled but untreated participants.
- Patient eligibility overview: Participants previously enrolled in any iECURE parent protocol, including both those who received IP dosing and those enrolled but not dosed, enabling comparison between treated and untreated cohorts.
Use This Page For
- Quick orientation before opening the registry record.
- Checking recruitment status, phase and sponsor at a glance.
- Connecting this trial to nearby guidelines, Drug Science and education.
What This Trial Is Studying
This LTFU is being conducted to assess long-term safety and durability of response in participants dosed with IP in a parent protocol, and to collect longitudinal natural history in enrolled but not dosed participants who also participated in a parent protocol.
Eligibility Snapshot
- : 1. Enrolled in an iECURE parent protocol and have either completed or discontinued that protocol
- Participant parent(s)/LAR is willing and able to adhere to the protocol requirements. 3. Consent was obtained by the participants parent(s)/LAR (and participant assent, where applicable), prior to any study-related data being collected.
Use the source registry for the full inclusion and exclusion criteria before discussing referral or enrolment.